Solvay Pharmaceuticals, Pharmacia & Upjohn Inc. and the Obsessive Compulsive Foundation have launched a new public awareness campaign to help children and adults recognize and treat obsessive-compulsive disorder.
Solvay Pharmaceuticals, Pharmacia & Upjohn Inc. and the Obsessive Compulsive Foundation have launched a new public awareness campaign to help children and adults recognize and treat obsessive-compulsive disorder.
The campaign, "Kids Like Me," will include a children's book, a brochure for parents, a toll-free OCD information line, a Website and television public service announcements featuring former game show host Marc Summers, who has OCD.
OCD is a biological brain disorder thought to be caused by an imbalance of the brain chemical seratonin.
According to a recent national survey, adults who had OCD while growing up waited an average of nearly 20 years before they sought treatment. Embarrassment, lack of knowledge about the disorder and fear of becoming misunderstood were the most commonly cited reasons for keeping silent.
The survey was conducted by Ketchum Public Relations Research and Measurement Department. It was sponsored by Solvay, based in Marietta, GA, and Pharmacia & Upjohn of Kalamazoo, MI. PR
Planning for Unique Challenges Faced by Cell & Gene Therapy Developers
May 8th 2024In an interview with Pharm Exec Associate Editor Don Tracy, Melissa Lattanzi, VP, Emerging Therapies, Cencora, discusses the unique challenges that developers of cell and gene therapies need to plan for when building their channel strategy.
The State of Mining Data Insights in the Life Sciences Industry – 2024
April 30th 2024A Frost & Sullivan industry-wide survey reveals which insights most pharmaceutical companies have mastered and which are still painful or impossible to extract and details the complexity of the process, the confidence companies have in their findings, and more. Hear Web Sun, President and Co-founder of Komodo Health, share what's driving these challenges and how you can overcome them.